UC Davis Bench-To-Bedside Research: Promising Treatment For Diabetes, Hypertension And Inflammatory
Featured on: Medical News Today
Publication date: Mar 28, 2009
Publication date: Mar 28, 2009
A soluble epoxide hydrolase enzyme (s-EH) inhibitor used in treating a variety of cardiovascular conditions has entered Phase II of human clinical trials to evaluate its efficacy. Researchers at UC Davis have high hopes that the compound will solve a variety of health issues related to diabetes, hypertension and inflammation
Read Full Article
Read Full Article
More Blood Pressure Articles
Heart Failure Strikes Younger African-Americans At The Same Rate As Older CaucasiansBattling Blood Pressure
Employee Cardiovascular Health Relates To Psychological Well-being
Blood Pressure Goal Missed By Two Thirds Of Patients
Arthritis Trial Leads To Potential Cure For High Blood Pressure
The 3Bs Of Stroke Risk
High Blood Pressure In Pregnancy
How Do Diabetes And High Blood Pressure Effect Each Other?
High Blood Pressure Can Impair Kidney Functions
Exenatide Once Weekly Improves Blood Pressure And Lipid Profile In Patients With Type 2 Diabetes










